Significance: Nonalcoholic fatty liver disease (NAFLD), characterized by liver triacylglycerol
build-up, has been growing in the global world in concert with the raised prevalence of …

Nonalcoholic steatohepatitis, a progressive form of nonalcoholic fatty liver disease (NAFLD),
is one of the most common hepatic diseases in children who present with particular risk …

You have in your hands, or at your fingertips, the first edition of the American Academy of
Pediatrics clinical practice guideline for evaluation and management of children and …

Nonalcoholic fatty liver disease (NAFLD) is a highly prevalent chronic liver disease that
occurs in the setting of insulin resistance and increased adiposity. It has rapidly evolved into …

We performed a Bayesian network meta‐analysis combining direct and indirect treatment
comparisons to assess the comparative effectiveness of pharmacological agents for the …

Alterations of methionine cycle in steatohepatitis, cirrhosis, and hepatocellular carcinoma
induce MAT1A decrease and MAT2A increase expressions with the consequent decrease of …

The objective of this technical report is to provide clinicians with evidence-based, actionable
information upon which to make assessment and treatment decisions for children and …

Non-alcoholic fatty liver disease (NAFLD) is an important health threat that is strongly linked
to components of metabolic syndrome, particularly the low-grade inflammatory changes …

Metformin, a biguanide is well known treatment for type 2 diabetes mellitus that has diverse
mechanism of actions. Various studies have elucidated the role of this drug in different …

Nonalcoholic fatty liver disease (NAFLD) is currently known as the most common liver
problem, characterized by excessive lipid accumulation in hepatocytes, which may progress …